Department of Sociology and the Health Sciences Research Institute, University of California, Merced, Merced, California.
Department of Behavioral and Community Health Sciences, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania.
Womens Health Issues. 2022 May-Jun;32(3):301-308. doi: 10.1016/j.whi.2022.01.007. Epub 2022 Mar 1.
We aimed to identify human papillomavirus (HPV) and HPV vaccine-related knowledge, attitudes, and beliefs among women aged 27-45 years, who became eligible for HPV vaccination in 2018.
Eight virtual focus groups were conducted with 52 unvaccinated cisgender women aged 27-45 years living in Southern California's Inland Empire. Themes related to women's knowledge, attitudes, and beliefs were systematically identified using the rigorous and accelerated data reduction technique.
The sample was diverse: 62% of participants were Hispanic, Black, or Asian; 17% identified as lesbian or bisexual; and annual household incomes ranged from $0 to $260,000 (median, $60,500). Key qualitative themes centered on 1) questions about HPV and HPV vaccination, 2) knowledge and beliefs about HPV and HPV vaccination, 3) concerns about vaccine side effects and safety, 4) low perceived benefits of vaccination, and 5) social factors influencing vaccine acceptance. Few participants were aware adults aged 27-45 years are eligible for HPV vaccination or that vaccination can still be beneficial after sexual debut. Many believed HPV vaccination caused serious side effects among adolescents and questioned whether safety had been adequately studied for newly eligible adults. Although many participants associated HPV vaccination with social stigma, some emphasized that vaccination was a way to exercise control over their health and prevent illness, given they could not always control the actions of their sexual contacts.
Findings provide insight into knowledge, attitudes, and beliefs about HPV and HPV vaccination among women aged 27-45 years, which may be useful for informing interventions to promote shared clinical decision-making between patients and health providers.
我们旨在确定 2018 年符合 HPV 疫苗接种条件的 27-45 岁女性中 HPV 和 HPV 疫苗相关的知识、态度和信念。
对居住在南加州内陆帝国的 52 名未接种 HPV 疫苗的 27-45 岁顺性别女性进行了 8 次虚拟焦点小组访谈。使用严格且加速的数据缩减技术,系统地确定与女性知识、态度和信念相关的主题。
该样本具有多样性:62%的参与者为西班牙裔、非裔或亚裔;17%的参与者自认为是女同性恋或双性恋;家庭年收入从 0 到 260000 美元不等(中位数为 60500 美元)。关键的定性主题集中在 1)HPV 和 HPV 疫苗接种相关问题,2)HPV 和 HPV 疫苗接种相关知识和信念,3)对疫苗副作用和安全性的担忧,4)对疫苗接种益处的低感知,以及 5)影响疫苗接种接受度的社会因素。很少有参与者知道 27-45 岁的成年人有资格接种 HPV 疫苗,或者在性行为开始后接种疫苗仍然有益。许多人认为 HPV 疫苗接种会在青少年中引起严重的副作用,并质疑新符合条件的成年人的安全性是否得到充分研究。尽管许多参与者将 HPV 疫苗接种与社会污名联系起来,但有些人强调,鉴于他们无法始终控制自己性伴侣的行为,接种疫苗是一种控制自身健康和预防疾病的方式。
研究结果深入了解了 27-45 岁女性对 HPV 和 HPV 疫苗的知识、态度和信念,这可能有助于为促进患者和卫生保健提供者之间的共同临床决策提供信息。